Cited by 79Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBalance, Gait, and Falls Prevention

An ambulatory dyskinesia monitor

Open access
Manson, A J·2000·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

OBJECTIVES: New treatments are now becoming available for the management of levodopa induced dyskinesias in Parkinsons's disease. However, assessment of their efficacy is limited by the inadequacies of current methods of dyskinesia measurement. The objective was to develop and validate a portable device capable of objectively measuring dyskinesias during normal daily activities. METHODS: A portable device was developed based on a triaxial accelerometer, worn on the shoulder, and a data recorder that can record levodopa induced dyskinesias. A computer program plots raw acceleration and acceleration over 0.5 Hz frequency bands against time. The acceleration in the different bands can then be compared with the raw acceleration trace, enabling identification and exclusion of confounding activities such as tremor and walking, which have a characteristic appearance on the trace. The validity of this device was assessed on 12 patients and eight age matched controls by comparing accelerations in the 1-3 Hz frequency band with established clinical dyskinesia rating scales. While wearing the monitor, subjects were videorecorded sitting and during dyskinesia provocation tasks, including mental activation tasks, eating, drinking, writing, putting on a coat, and walking. The dyskinesias were graded with both modified abnormal involuntary movement (AIM) and Goetz scales. The clinical ratings were then compared with the mean acceleration scores. RESULTS: Acceleration in the 1-3 Hz frequency band correlated well against both scales, during all individual tasks. Acceleration produced by normal voluntary activity (with the exception of walking, which produced large accelerations, even in controls) was small compared with dyskinetic activity. With walking excluded, the mean acceleration over the rest of the recording time correlated strongly with both the modified AIM (Spearman's rank (r=0.972, p<0.001) and Goetz (r=0.951, p<0.001) scales. CONCLUSIONS: This method provides an accurate, objective means for dyskinesia assessment, and compares favourably with established methods currently used.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp.68.2.196

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Manson et al showed a correlation between accelerometer output and severity of dyskinesia in patients with Parkinson's disease.

    “Manson and colleagues showed that there is a correlation between accelerometer output and severity of dyskinesia in patients with PD.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Manson, A. J.
Affiliations
National Hospital for Neurology and Neurosurgery (GB)
Corresponding author
Manson, A J
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2000-02-01
Volume
68
Issue
2
Pages
196-201
ISSN
0022-3050 (ISSN-L)
OpenAlex
W2143024867
Cited by
79
References
20
Citations by year
2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 3 · 2018: 1 · 2017: 7 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 4 · 2012: 6
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
Keywords
levodopa-induced dyskinesia, Parkinson's disease, ambulatory monitoring, triaxial accelerometer, wearable devices, Abnormal Involuntary Movement Scale, frequency band analysis, treatment efficacy assessment
MeSH terms
Adult, Aged, Antiparkinson Agents, Dyskinesia, Drug-Induced, Electrophysiology, Female, Humans, Levodopa, Male, Middle Aged, Parkinson Disease, Sensitivity and Specificity, Severity of Illness Index, Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review